Results 221 to 230 of about 63,152 (354)

Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study [PDF]

open access: gold, 2023
Antonio Gidaro   +11 more
openalex   +1 more source

Immunometabolic Rewiring of Dendritic Cells to Overcome Glutamine‐Driven Immune Suppression in Colorectal Cancer

open access: yesAdvanced Science, Volume 13, Issue 5, 27 January 2026.
T26 is an immunometabolic prodrug that modulates colorectal cancer cells. It blocks glutamine metabolism and enhances STING signaling, which promotes the release of reprogrammed extracellular vesicles. These vesicles drive dendritic cell maturation and CD8⁺ T cell activation, thereby strengthening antitumor immunity and improving the effectiveness of ...
Bingjie Zhang   +13 more
wiley   +1 more source

Microvesicles from Turmeric Extracts Contain Curcuminoids and Modulate Macrophage Polarization and Migration. [PDF]

open access: yesPharmaceutics
Tacconi S   +9 more
europepmc   +1 more source

High‐Quality Perovskite Single Crystal Fabrication via Self‐Assembled Microvesicles Assisted Localized Precursor Release [PDF]

open access: bronze
Shuyu Shi   +10 more
openalex   +1 more source

PD‐L1 on Tumor‐Derived Extracellular Vesicles Induces CD8+ T Cell Terminal Exhaustion and Mediates Anti‐PD‐1 Resistance in Head and Neck Squamous Cell Carcinoma

open access: yesAdvanced Science, Volume 13, Issue 4, 19 January 2026.
Immunotherapy fails in head and neck squamous cell carcinoma (HNSCC) due to terminally exhausted T (Texterm) cells. Tumor‐derived PD‐L1+ extracellular vesicles promote CD8‐Texterm cells differentiation by upregulating BATF. Stromal Texterm density serves as a potent biomarker for predicting immunotherapy resistance, highlighting a novel EV‐mediated ...
Ruihua Fang   +15 more
wiley   +1 more source

Microvesicle Profiles in Patients with HIV, HBV, and HCV Infections: An Exploratory Pilot Study. [PDF]

open access: yesMicroorganisms
Dryllis G   +15 more
europepmc   +1 more source

Nanobiotechnology‐Based Approaches for Targeted Glioma Therapy

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 1, January 2026.
Nanoparticle systems cross the blood–brain barrier to deliver drugs precisely to glioma cells. Lipid, polymeric, and magnetic carriers enable controlled release, tumor targeting, and microenvironment modulation. These nanoplatforms enhance chemotherapy, radiotherapy, and immunotherapy, improving therapeutic efficacy while reducing systemic toxicity ...
Jinwei Li   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy